Equity - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Jul. 31, 2020
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	280,000,000		280,000,000
Preferred stock, shares authorized (in shares)	50,000,000		50,000,000
Common stock issued in connection with stock options exercised (in shares)	1,932
Common stock issued through the dividend reinvestment plan (in shares)	847	605
Number of shares of stock grants withheld (in shares)	60,693	69,721
Repurchases of shares (in shares)	7,000
Treasury stock acquired (in dollars per share)	$ 161.29
Stock repurchase program, remaining authorized amount	$ 315,019,000
Forward contract indexed to issuer's equity (in shares)	2,000,000
Forward contract indexed to equity, settlement fair value (in dollars per share)	$ 247.30
2020 Stock Repurchase Program
Class of Stock [Line Items]
Stock repurchase program, authorized amount				$ 500,000,000
Continuous Equity Program CEP V
Class of Stock [Line Items]
Maximum value of shares of common stock that can be sold (in dollars)	$ 1,000,000,000
Common stock sold under CEP V (in shares)	0
Common stock value, remaining to be authorized under continuous equity program	$ 705,961,000
Maximum | Continuous Equity Program CEP V
Class of Stock [Line Items]
Percentage of compensation received by sales agent	1.50%
Restricted Stock and Common Stock Converted from Performance Shares
Class of Stock [Line Items]
Equity instruments granted (in shares)	151,053	132,135
Restricted stock
Class of Stock [Line Items]
Equity instruments granted (in shares)	91,037	78,082
Stock issued during period, shares, share-based compensation, forfeited (in shares)	147	1,181